PEG-somatropin (GenSci004)

pegylated somatropin · Changchun GeneScience Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PEG-somatropin (GenSci004), covering 2023-09-11 to 2023-09-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency [Phase 3]

See pricing